论文部分内容阅读
Tacrolimus(Prograf,Astellas Pharma Europe Ltd,Staines,United Kingdom;referred to as tacrolimus-BID)is an immunosuppressive agent to prevent and treat allograft rejection in kidney transplant recipients in combination with mycophenolate mofetil,corticoster